Table 1 Characteristics of human and mouse Fc receptors

From: Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection

Fc receptor

Function

ITAM, ITIM or ITAMi

Binding affinity for antibody isotypesa

Cell type-specific expression

Human

FcμR

Endocytosis

None

IgM (+++)

B cells; subpopulations of T cells and NK cells

Fcα/μR

Endocytosis

None

IgM (+++), IgA (+++)

Subpopulations of B cells and DCs

FcαRI

Cell activation or inhibition

ITAM or ITAMi

IgA (++)

Neutrophils and eosinophils; subpopulations of monocytes/macrophages and DCs

FcεRI

Cell activation

ITAM

IgE (+++)

Basophils, mast cells and platelets; subpopulations of monocytes/macrophages, DCs and eosinophils

FcεRII

IgE regulation

None

IgE (++)

B cells, eosinophils and platelets; inducible expression on monocytes/macrophages and DCs

FcγRI

Cell activation

ITAM

IgG1 (+++), IgG3 (+++), IgG4 (+++)

Monocytes/macrophages; inducible expression on neutrophils and mast cells

FcγRIIA

Cell activation or inhibition

ITAM or ITAMi

IgG1 (++), IgG2 (++), IgG3 (++), IgG4 (++)

Monocytes/macrophages, neutrophils, DCs, basophils, mast cells, eosinophils and platelets

FcγRIIB

Cell inhibition

ITIM

IgG1 (+), IgG2 (+), IgG3 (++), IgG4 (++)

B cells, DCs and basophils; majority of monocytes/macrophages (except alveolar macrophages); subpopulations of neutrophils

FcγRIICb

Cell activation

ITAM

IgG1 (+), IgG2 (+), IgG3 (++), IgG4 (++)

NK cells

FcγRIIIA

Cell activation or inhibition

ITAM or ITAMi

IgG1 (++), IgG2 (+), IgG3 (+++), IgG4 (++)

NK cells and monocytes/macrophages; uncertain expression on neutrophils

FcγRIIIB

Cell activation or decoy receptor

None

IgG1 (++), IgG3 (++)

Neutrophils; subpopulations of basophils

Mouse

FcμR

Endocytosis

None

IgM (+++)

B cells

Fcα/μR

Endocytosis

None

IgM (+++), IgA (+++)

B cells; subpopulations of DCs

FcεRI

Cell activation

ITAM

IgE (+++)

Basophils and mast cells; inducible expression on neutrophils and DCs

FcεRII

IgE regulation

None

IgE (+++)

B cells; subpopulations of DCs

FcγRI

Cell activation

ITAM

IgG2a (+++), IgG2b (++)

Neutrophils; subpopulations of monocytes/macrophages and DCs

FcγRIIB

Cell inhibition

ITIM

IgG1 (++), IgG2a (++), IgG2b (++), IgE (+)

B cells, monocytes/macrophages, neutrophils, DCs, basophils, mast cells and eosinophils

FcγRIII

Cell activation or inhibition

ITAM or ITAMi

IgG1 (++), IgG2a (++), IgG2b (++), IgE (+)

NK cells, monocytes/macrophages, neutrophils, DCs, basophils, mast cells and eosinophils

FcγRIV

Cell activation

ITAM

IgG2a (+++), IgG2b (+++), IgE (++)

Monocytes/macrophages, neutrophils and DCs

  1. DC, dendritic cell; Fc, crystallizable fragment; FcR, Fc receptor; ITAM, immunoreceptor tyrosine-based activation motif; ITAMi, inhibitory ITAM; ITIM, immunoreceptor tyrosine-based inhibitory motif; NK, natural killer. aMeasured in terms of the association constant (Ka): +++, >1 × 107 M−1; ++, 1 × 105–1 × 107 M−1; +, <1 × 105 M−1. bEncoded by a pseudogene that is only expressed in a fraction of the human population owing to allelic polymorphism.